Back to News
Market Impact: 0.34

Regeneron (REGN) Surpasses Q1 Earnings and Revenue Estimates

REGN
Corporate EarningsCompany FundamentalsAnalyst EstimatesHealthcare & Biotech

Regeneron reported quarterly EPS of $9.47, above the Zacks Consensus Estimate of $8.52 and up from $8.22 a year ago. The 11.2% beat versus consensus indicates stronger-than-expected profitability, supporting a positive read-through for company fundamentals. The release is likely to be stock-specific rather than sector-wide.

Analysis

Regeneron reported quarterly EPS of $9.47, above the Zacks Consensus Estimate of $8.52 and up from $8.22 a year ago. The 11.2% beat versus consensus indicates stronger-than-expected profitability, supporting a positive read-through for company fundamentals. The release is likely to be stock-specific rather than sector-wide.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.38

Ticker Sentiment

REGN0.62